Mebroqualone
Mebroqualone is a quinazolinone-class GABAergic sedative and hypnotic medication. It is a derivative of the drug methaqualone, which was widely used in the 1960s and 1970s for its anxiolytic, sedative, and muscle relaxant properties. Mebroqualone is distinguished from methaqualone by the presence of a bromine atom in its chemical structure.
Pharmacology
Mebroqualone acts as a positive allosteric modulator of the GABA_A receptor, enhancing the effects of the neurotransmitter gamma-aminobutyric acid (GABA). This action results in increased neuronal inhibition, leading to its sedative and hypnotic effects. The drug's pharmacological profile is similar to that of methaqualone, but the addition of the bromine atom may alter its potency and duration of action.
Medical Uses
Mebroqualone was primarily used for its sedative and hypnotic properties. It was prescribed for the treatment of insomnia and anxiety disorders. However, due to its potential for abuse and dependence, its medical use has been largely discontinued in favor of safer alternatives.
Side Effects
Common side effects of mebroqualone include drowsiness, dizziness, and ataxia. In higher doses, it can cause respiratory depression, hypotension, and coma. Long-term use can lead to tolerance, dependence, and withdrawal symptoms upon discontinuation.
Legal Status
Due to its potential for abuse and the availability of safer alternatives, mebroqualone is a controlled substance in many countries. Its legal status varies, but it is generally classified alongside other quinazolinone derivatives.
History
Mebroqualone was developed as an alternative to methaqualone in an attempt to find a compound with similar therapeutic effects but a lower potential for abuse. Despite these efforts, mebroqualone was found to have a similar abuse potential and was eventually subjected to the same regulatory controls.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
